Pharmaceutics: lung toxicity of anticancer drugs

Placebo-controlled trial of bexarotene, a retinoid x receptor agonist, as maintenance therapy for patients treated with chemotherapy for advanced non-small-cell lung cancer.

Clinical lung cancer·2004

Multi-institutional phase I/II trial of oral bexarotene in combination with cisplatin and vinorelbine in previously untreated patients with advanced non-small-cell lung cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001

A phase II study of the efficacy of recombinant interferon gamma in relapsing ovarian adenocarcinoma.

American journal of clinical oncology·1988

Phase I/II study of recombinant interferon gamma in advanced renal cell carcinoma.

The Journal of urology·1988

A randomized phase I/II study of continuous versus intermittent intravenous interferon gamma in patients with metastatic melanoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1987

Hyponatremia and other toxic effects during a phase I trial of recombinant human gamma interferon and vinblastine.

Cancer treatment reports·1986

"This Is Loneliness, Helplessness, Desolation…": Exploring the Emotions and Emotion Regulation Experiences of Mothers of Children Diagnosed With Acute Lymphoblastic Leukemia.

Cancer nursing·2026

Menopausal Symptoms, Depression, and Sleep Quality Among Postmenopausal Women With and Without Breast Cancer.

Cancer nursing·2026

Longitudinal Use of the Pediatric PRO-CTCAE in Heterogeneous Oncology Population is Feasible and Highlights Individuality of the Adverse Event Experience.

Cancer nursing·2026

The Impact of Social Determinants on Posttraumatic Growth Among Young Adult Childhood Cancer Survivors.

Cancer nursing·2026

Ringing the Bell in Cancer Care: A Scoping Review of Patients', Caregivers', and Healthcare Professionals' Experiences and Implications for Oncology Nursing.

Cancer nursing·2026

Ethnic Differences in Psychosocial Factors for Cancer Survivorship Among Asian American Breast Cancer Survivors: Secondary Outcomes of a Randomized Controlled Trial.

Cancer nursing·2026

Organophosphate pesticide poisoning: benefits and limitations of oxime therapy.

Clinical toxicology (Philadelphia, Pa.)·2026

SHR-2004, a Humanized Monoclonal Antibody Targeting Factor XI, for Preventing Venous Thromboembolism After Ovarian Cancer Surgery: A Randomized, Active-Controlled Phase 2 Study.

American journal of hematology·2026

Borneol-based nanoparticles encapsulating Doxorubicin/Sodium tanshinone IIA sulfonate enhance the effect of anti-glioma and alleviate cardiotoxicity.

Cytotechnology·2026

Contrasting Embryogenic Trajectories Reveal Spatial Control as a Key Determinant of Embryogenic Competence in Theobroma cacao L.

Physiologia plantarum·2026

Cordyceps sinensis and Sonodynamic Therapy in Non-Small Cell Lung Cancer: Pharmacological Basis, Therapeutic Potential, and Future Directions.

International journal of nanomedicine·2026

Shikonin in Hepatocellular Carcinoma: Bridging Metabolic Disruption and Immunomodulation.

Journal of hepatocellular carcinoma·2026

Related Experiment Videos

Pharmaceutics: lung toxicity of anticancer drugs

Related Concept Videos

Placebo-controlled trial of bexarotene, a retinoid x receptor agonist, as maintenance therapy for patients treated with chemotherapy for advanced non-small-cell lung cancer.

Multi-institutional phase I/II trial of oral bexarotene in combination with cisplatin and vinorelbine in previously untreated patients with advanced non-small-cell lung cancer.

A phase II study of the efficacy of recombinant interferon gamma in relapsing ovarian adenocarcinoma.

Phase I/II study of recombinant interferon gamma in advanced renal cell carcinoma.

A randomized phase I/II study of continuous versus intermittent intravenous interferon gamma in patients with metastatic melanoma.

Hyponatremia and other toxic effects during a phase I trial of recombinant human gamma interferon and vinblastine.

"This Is Loneliness, Helplessness, Desolation…": Exploring the Emotions and Emotion Regulation Experiences of Mothers of Children Diagnosed With Acute Lymphoblastic Leukemia.

Menopausal Symptoms, Depression, and Sleep Quality Among Postmenopausal Women With and Without Breast Cancer.

Longitudinal Use of the Pediatric PRO-CTCAE in Heterogeneous Oncology Population is Feasible and Highlights Individuality of the Adverse Event Experience.

The Impact of Social Determinants on Posttraumatic Growth Among Young Adult Childhood Cancer Survivors.

Ringing the Bell in Cancer Care: A Scoping Review of Patients', Caregivers', and Healthcare Professionals' Experiences and Implications for Oncology Nursing.

Ethnic Differences in Psychosocial Factors for Cancer Survivorship Among Asian American Breast Cancer Survivors: Secondary Outcomes of a Randomized Controlled Trial.

Organophosphate pesticide poisoning: benefits and limitations of oxime therapy.

SHR-2004, a Humanized Monoclonal Antibody Targeting Factor XI, for Preventing Venous Thromboembolism After Ovarian Cancer Surgery: A Randomized, Active-Controlled Phase 2 Study.

Borneol-based nanoparticles encapsulating Doxorubicin/Sodium tanshinone IIA sulfonate enhance the effect of anti-glioma and alleviate cardiotoxicity.

Contrasting Embryogenic Trajectories Reveal Spatial Control as a Key Determinant of Embryogenic Competence in Theobroma cacao L.

Cordyceps sinensis and Sonodynamic Therapy in Non-Small Cell Lung Cancer: Pharmacological Basis, Therapeutic Potential, and Future Directions.

Shikonin in Hepatocellular Carcinoma: Bridging Metabolic Disruption and Immunomodulation.

Related Experiment Videos

Pharmaceutics: lung toxicity of anticancer drugs

Related Concept Videos

Related Articles